Evidence map›Paper›PMID 27168434›Full record

Trial reportThe New England journal of medicine2016

Patterns of Growth and Decline in Lung Function in Persistent Childhood Asthma.

M J McGeachie, K P Yates, X Zhou, F Guo, A L Sternberg, M L Van Natta, R A Wise, S J Szefler, S Sharma, A T Kho and 27 more

Registry-linked trialOpen access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The New England journal of medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00000575 (Childhood Asthma Management Program), which is not on this map. Cited by 277 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
277citing papers in PubMed, 9 pooled it
39.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00000575 phase3completednot on this map

Childhood Asthma Management Program

TypeinterventionalSponsorJohns Hopkins Bloomberg School of Public HealthRan1991 to 2012Enrolled1,041ConditionsAsthma, Lung DiseasesArmsPlacebo, Nedocromil, Budesonide
3 · Its place in the literature

Who cites it

277 citing papers in PubMed, 9 syntheses or guidelines pooled it, 593 citations in OpenAlex.

  1. Pooled it
  2. Epidemiology of severe asthma in children: a systematic review and meta-analysis.European respiratory review : an official journal of the European Respiratory Society · 2024
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Asthma, bronchial hyperresponsiveness, allergy and lung function development until early adulthood: A systematic literature review.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2021
    Pooled it
  8. Pooled it
  9. Pooled it
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. The acuity of paediatric asthma in the emergency department worsened after the COVID-19 pandemic in Alberta, Canada.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2026
    Article
  20. Article

217 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

37 authors at 13 institutions in 4 countries.

M J McGeachie *
K P Yates *
X Zhou
F Guo
A L Sternberg
M L Van Natta
R A Wise
S J Szefler
S Sharma
A T Kho
M H Cho
D C Croteau-Chonka
P J Castaldi
G Jain
A Sanyal
Y Zhan
B R Lajoie
J Dekker
J Stamatoyannopoulos
R A Covar
R S Zeiger
N F Adkinson
P V Williams
H W Kelly
H Grasemann
J M Vonk
G H Koppelman
D S Postma
B A Raby
I Houston
Q Lu
A L Fuhlbrigge
K G Tantisira
E K Silverman
J Tonascia
S T Weiss *
R C Strunk *
Johns Hopkins University · USUniversity Medical Center Groningen · NLUniversity of Massachusetts Chan Medical School · USNational Jewish Health · USAllergy, Asthma and Clinical Research Center · USBrigham and Women's Hospital · USHoward Hughes Medical Institute · USKaiser Permanente · USPulmonary and Critical Care Associates · USUniversity of Colorado Denver · USUniversity of New Mexico · USUniversity of Washington · USWashington University in St. Louis · US

Funding

THE PHARMACOGENETICS OF ASTHMA TREATMENTU01HL065899 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI TANTISIRA, KELAN G, WEISS, SCOTT T · 2000 to 2014
$38.5M
Genetic Epidemiology of COPDU01HL089856 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SILVERMAN, EDWIN K · 2007 to 2021
$20.7M
(2 of 2) Genetic Epidemiology of COPDR01HL089856 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SILVERMAN, EDWIN K · 2012 to 2016
$18.9M
Structural Annotation of the Human GenomeR01HG003143 · NHGRI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Job Dekker · 2003 to 2026
$15.4M
SYSTEMS APPROACHES TO THE EPIDEMIOLOGY, GENETICS AND GENOMICS OF LUNG DISEASEST32HL007427 · NHLBI · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI DAWN L DEMEO, Edwin K Silverman · 1985 to 2026
$13.6M
A Comprehensive Catalog of Dnasel Hypersensitive SitesU54HG007010 · NHGRI · UNIVERSITY OF WASHINGTON · PI STAMATOYANNOPOULOS, JOHN A · 2012 to 2016
$12.4M
Systems Biology, Bioinformatics, and BiostatisticsP01HL105339 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SILVERMAN, EDWIN K · 2011 to 2015
$12.2M
Statistical GeneticsP01HL083069 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI WEISS, SCOTT T · 2007 to 2011
$12.2M
Using Integrative Genomics To Identify and Characterize Emphysema-Associated eQTLR01HL124233 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI CASTALDI, PETER · 2014 to 2024
$7.1M
Fine Mapping of COPD Susceptibility GenesR01HL075478 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SILVERMAN, EDWIN K · 2004 to 2012
$6.4M
Identifying Genetic Determinants of Severe, Early-Onset COPDR01HL113264 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI CHO, MICHAEL H., SILVERMAN, EDWIN K · 2012 to 2016
$6.0M
Enhancing Nrf2 by Sulforaphane Treatment in COPDU01HL105569 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI BISWAL, SHYAM, WISE, ROBERT A. · 2010 to 2012
$5.0M
Howard Hughes Medical InstituteNHGRI NIH HHS HG003143NHGRI NIH HHS HG007010NHGRI NIH HHS R01 HG003143NHGRI NIH HHS U54 HG007010NHLBI NIH HHS K08 HL097029NHLBI NIH HHS K08-HL097029NHLBI NIH HHS K08 HL102265NHLBI NIH HHS K08-HL102265NHLBI NIH HHS K25 HL091124NHLBI NIH HHS P01 HL083069NHLBI NIH HHS P01-HL083069NHLBI NIH HHS P01 HL105339NHLBI NIH HHS P01-HL105339NHLBI NIH HHS R01 HL075478NHLBI NIH HHS R01-HL075478NHLBI NIH HHS R01 HL089856NHLBI NIH HHS R01-HL089856NHLBI NIH HHS R01 HL113264NHLBI NIH HHS R01-HL113264NHLBI NIH HHS R01 HL124233NHLBI NIH HHS R01-HL124233NHLBI NIH HHS R01 HL127200NHLBI NIH HHS R01HL127200NHLBI NIH HHS R21 HL120794NHLBI NIH HHS R21HL120794NHLBI NIH HHS R33 HL120794NHLBI NIH HHS T32 HL007427NHLBI NIH HHS T32-HL007427NHLBI NIH HHS U01 HL065899NHLBI NIH HHS U01-HL065899NHLBI NIH HHS U01 HL075408NHLBI NIH HHS U01HL075408NHLBI NIH HHS U01 HL089856NHLBI NIH HHS U01 HL091075NHLBI NIH HHS U01-HL091075NHLBI NIH HHS U01 HL105569NHLBI NIH HHS U01-HL105569NINR NIH HHS R01 NR013391NINR NIH HHS R01-NR013391
6 · The paper itself

Abstract

backgroundTracking longitudinal measurements of growth and decline in lung function in patients with persistent childhood asthma may reveal links between asthma and subsequent chronic airflow obstruction.

methodsWe classified children with asthma according to four characteristic patterns of lung-function growth and decline on the basis of graphs showing forced expiratory volume in 1 second (FEV1), representing spirometric measurements performed from childhood into adulthood. Risk factors associated with abnormal patterns were also examined. To define normal values, we used FEV1 values from participants in the National Health and Nutrition Examination Survey who did not have asthma.

resultsOf the 684 study participants, 170 (25%) had a normal pattern of lung-function growth without early decline, and 514 (75%) had abnormal patterns: 176 (26%) had reduced growth and an early decline, 160 (23%) had reduced growth only, and 178 (26%) had normal growth and an early decline. Lower baseline values for FEV1, smaller bronchodilator response, airway hyperresponsiveness at baseline, and male sex were associated with reduced growth (P<0.001 for all comparisons). At the last spirometric measurement (mean [±SD] age, 26.0±1.8 years), 73 participants (11%) met Global Initiative for Chronic Obstructive Lung Disease spirometric criteria for lung-function impairment that was consistent with chronic obstructive pulmonary disease (COPD); these participants were more likely to have a reduced pattern of growth than a normal pattern (18% vs. 3%, P<0.001).

conclusionsChildhood impairment of lung function and male sex were the most significant predictors of abnormal longitudinal patterns of lung-function growth and decline. Children with persistent asthma and reduced growth of lung function are at increased risk for fixed airflow obstruction and possibly COPD in early adulthood. (Funded by the Parker B. Francis Foundation and others; ClinicalTrials.gov number, NCT00000575.).

Indexed as

Administration, InhalationAdolescentAnti-Inflammatory AgentsAsthmaBronchodilator AgentsBudesonideChildChild, PreschoolFemaleForced Expiratory VolumeHumansKaplan-Meier EstimateLongitudinal StudiesLungMaleNedocromilAnti-Inflammatory AgentsBronchodilator AgentsBudesonideNedocromil

Identifiers

PMID27168434
PMCPMC5032024
OpenAlexW2357940608

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.